Abreva overseas
This article was originally published in The Tan Sheet
Executive Summary
Cairo, Egypt-based Biopharm Group will manufacture, market Avanir Pharmaceuticals' docosanol 10% cream in Egypt, other Middle East countries under licensing agreement announced Jan. 30. San Diego-based Avanir will receive milestone payments, product sale royalties; marketing approvals are expected to take approximately 18 months. Regulatory approvals in Canada, where cream will be marketed by GlaxoSmithKline, Israel (CTS Chemical) and South Korea (Boryung) expected in second or third quarter. Firm has entered research collaboration with Shanghai Asiatic Pharmaceutical (China) for clinical trials on genital herpes, herpes labialis, herpes zoster (shingles)...
|
Cairo, Egypt-based Biopharm Group will manufacture, market Avanir Pharmaceuticals' docosanol 10% cream in Egypt, other Middle East countries under licensing agreement announced Jan. 30. San Diego-based Avanir will receive milestone payments, product sale royalties; marketing approvals are expected to take approximately 18 months. Regulatory approvals in Canada, where cream will be marketed by GlaxoSmithKline, Israel (CTS Chemical) and South Korea (Boryung) expected in second or third quarter. Firm has entered research collaboration with Shanghai Asiatic Pharmaceutical (China) for clinical trials on genital herpes, herpes labialis, herpes zoster (shingles).... |